Ramón Cacabelos
Impact in
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
- Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disorders and Treatments
- Neurological Disease Mechanisms and Treatments
Papers in
- Neurology 46
- Neurological Disorders and Treatments 22
- Neuroinflammation and Neurodegeneration Mechanisms 19
- Neurological Disease Mechanisms and Treatments 16
- Co-authors
- L. Fernández‐NovoaX.A. AlvarezValter LombardiClara TorrellasIván CarreraJuan C. CarrilJosé Javier Miguel-HidalgoLola Corzo
- Journals
- International Journal of Molecular Sciences (11 papers)European Neuropsychopharmacology (8 papers)Inflammation Research (6 papers)Alzheimer s & Dementia (6 papers)Pharmacogenomics (6 papers)
- Partner nations
- SpainJapanUnited States
In The Last Decade
Ramón Cacabelos
254 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Biological Psychiatry 522
- Neurology 1.4k
- Pharmacology 1.5k
- Physiology 2.3k
- Pharmacology 737
Countries citing papers authored by Ramón Cacabelos
This map shows the geographic impact of Ramón Cacabelos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramón Cacabelos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramón Cacabelos more than expected).
Fields of papers citing papers by Ramón Cacabelos
This network shows the impact of papers produced by Ramón Cacabelos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramón Cacabelos. The network helps show where Ramón Cacabelos may publish in the future.
Co-authors
The 25 scholars most cited alongside Ramón Cacabelos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 1 | |
| 5 | 2018 | 52 | |
| 6 | 2018 | 54 | |
| 7 | 2016 | 2 | |
| 8 | A genomic approach to histamine function | 2016 | 1 |
| 9 | 2016 | 42 | |
| 10 | 2014 | 7 | |
| 11 | 2010 | 24 | |
| 12 | 2005 | 44 | |
| 13 | 2003 | 49 | |
| 14 | 2002 | 30 | |
| 15 | 2002 | 7 | |
| 16 | Enfermedad de Alzheimer. Presente terapéutico y retos futuros (segunda parte) | 2001 | 1 |
| 17 | 2000 | 56 | |
| 18 | Evaluación neuropsicológica de la demencia senil en atención primaria | 1997 | 3 |
| 19 | Alzheimer's disease: Scientific progress for future trends | 1993 | 2 |
| 20 | GRF-induced GH response in attention-deficit hyperactivity disorder. | 1990 | 3 |
About Ramón Cacabelos
Ramón Cacabelos is a scholar working on Neurology, Biological Psychiatry, Pharmacology, Pharmacology and Physiology, having authored 270 papers that have together received 6.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (58 papers), Cholinesterase and Neurodegenerative Diseases (52 papers), Computational Drug Discovery Methods (44 papers), Pharmacogenetics and Drug Metabolism (35 papers), Neurological Disorders and Treatments (22 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers), Neurological Disease Mechanisms and Treatments (16 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Biological Psychiatry (522 citations), Neurology (1.4k citations), Pharmacology (1.5k citations), Physiology (2.3k citations) and Pharmacology (737 citations). Ramón Cacabelos has collaborated with scholars based in Spain, Japan and United States. Frequent co-authors include L. Fernández‐Novoa, X.A. Alvarez, Valter Lombardi, Clara Torrellas, Iván Carrera, Juan C. Carril, José Javier Miguel-Hidalgo, Lola Corzo, Carmen Vigo and Antón Álvarez. Their work appears in journals such as International Journal of Molecular Sciences, European Neuropsychopharmacology, Inflammation Research, Alzheimer s & Dementia and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.